Skip to main content
Erschienen in: Indian Journal of Gastroenterology 2/2017

29.03.2017 | Case Series

Gastrointestinal manifestations of melioidosis: A single center experience

verfasst von: Nitin Jagtap, Harshal Shah, Anuradha Kancharla, Manu Tandan, Partha Pal, Sundeep Lakhtakia, Mohan Ramchandani, D. N. Reddy

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Melioidosis, being increasing, is reported from India. Gastrointestinal manifestations are typically reported as unusual cause of liver and/or splenic abscess. We aimed to describe various gastrointestinal manifestation of melioidosis in the present study. We retrospectively collected data of culture positive melioidosis cases from hospital database during August 2014–October 2016 at Asian Institute of Gastroenterology, Hyderabad. A total of nine culture positive cases (8 male) of melioidosis with median age of 40 years (range 23–66) were analyzed. Median duration of symptoms was 45 days. Two patients were being treated as tuberculosis. Three patients presented with liver abscess with two of them having simultaneous splenic abscess, and one had prostatic abscess. Three patients (43%) with history of acute pancreatitis had infected pancreatic collection, and one patient had left empyema with splenic abscess. One patient had wound infection with left lower limb cellulitis, presented as acute in chronic liver failure and another as spontaneous bacterial peritonitis (SBP). Diabetes and/or alcoholism was present in all patients. Seven patients had disseminated organ involvement. Seven patients underwent percutaneous intervention for drainage of abscess. Induction therapy as ceftazidime (n=4) or meropenem (n=5) followed by continuation therapy as oral cotrimoxazole (n=6) and doxycycline (n=1) was given. Six patients completed therapy and asymptomatic at end of follow up. Two patients died in the study period. One patient died due to acute-on-chronic liver failure (ACLF) with acute kidney injury and the other due to cardiac failure. One patient with SBP had lost to follow up. Apart from being unusual cause of liver/splenic abscess, melioidosis can present with infection of pancreatic collection, SBP, and infection in a compensated cirrhosis which can precipitate ACLF. Early recognition and specific therapy can improve prognosis.
Literatur
2.
Zurück zum Zitat Cousins S. India is at high risk from surge in cases of melioidosis, warn researchers. BMJ. 2016;352:i275.CrossRefPubMed Cousins S. India is at high risk from surge in cases of melioidosis, warn researchers. BMJ. 2016;352:i275.CrossRefPubMed
3.
Zurück zum Zitat Prakash A, Thavaselvam D, Kumar A, et al. Isolation, identification and characterization of Burkholderia pseudomallei from soil of coastal region of India. Spring. 2014;3:438.CrossRef Prakash A, Thavaselvam D, Kumar A, et al. Isolation, identification and characterization of Burkholderia pseudomallei from soil of coastal region of India. Spring. 2014;3:438.CrossRef
4.
Zurück zum Zitat Chong VH, Lim KS, Sharif F. Pancreatic involvement in melioidosis. JOP. 2010;11:365–8.PubMed Chong VH, Lim KS, Sharif F. Pancreatic involvement in melioidosis. JOP. 2010;11:365–8.PubMed
5.
Zurück zum Zitat Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010;4:e900.CrossRefPubMedPubMedCentral Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010;4:e900.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Vidyalakshmi K, Lipika S, Vishal S, et al. Emerging clinico-epidemiological trends in melioidosis: analysis of 95 cases from western coastal India. Int J Infect Dis. 2012;16:e491–7.CrossRefPubMed Vidyalakshmi K, Lipika S, Vishal S, et al. Emerging clinico-epidemiological trends in melioidosis: analysis of 95 cases from western coastal India. Int J Infect Dis. 2012;16:e491–7.CrossRefPubMed
7.
Zurück zum Zitat Jesudason MV, Anbarasu A, John TJ. Septicaemic melioidosis in a tertiary care hospital in South India. Indian J Med Res. 2003;117:119–21.PubMed Jesudason MV, Anbarasu A, John TJ. Septicaemic melioidosis in a tertiary care hospital in South India. Indian J Med Res. 2003;117:119–21.PubMed
8.
Zurück zum Zitat Vandana KE, Mukhopadhyay C, Tellapragada C, et al. Seroprevalence of Burkholderia pseudomallei among adults in coastal areas in southwestern India. PLoS Negl Trop Dis. 2016;10:e0004610.CrossRefPubMedPubMedCentral Vandana KE, Mukhopadhyay C, Tellapragada C, et al. Seroprevalence of Burkholderia pseudomallei among adults in coastal areas in southwestern India. PLoS Negl Trop Dis. 2016;10:e0004610.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Shaw T, Tellapragada C, Eshwara VK, et al. The antibiotics of choice for the treatment of melioidosis in Indian set up. Indian J Med Microbiol. 2016;34:353–4.CrossRefPubMed Shaw T, Tellapragada C, Eshwara VK, et al. The antibiotics of choice for the treatment of melioidosis in Indian set up. Indian J Med Microbiol. 2016;34:353–4.CrossRefPubMed
10.
Zurück zum Zitat Lee SS, Liu YC, Chen YS, et al. Melioidosis: two indigenous cases in Taiwan. J Formos Med Assoc. 1996;95:562–6.PubMed Lee SS, Liu YC, Chen YS, et al. Melioidosis: two indigenous cases in Taiwan. J Formos Med Assoc. 1996;95:562–6.PubMed
Metadaten
Titel
Gastrointestinal manifestations of melioidosis: A single center experience
verfasst von
Nitin Jagtap
Harshal Shah
Anuradha Kancharla
Manu Tandan
Partha Pal
Sundeep Lakhtakia
Mohan Ramchandani
D. N. Reddy
Publikationsdatum
29.03.2017
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 2/2017
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-017-0741-9

Weitere Artikel der Ausgabe 2/2017

Indian Journal of Gastroenterology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.